Compass Therapeutics, Inc.·4

Apr 28, 1:29 PM ET

Chiniara Ellen 4

4 · Compass Therapeutics, Inc. · Filed Apr 28, 2022

Insider Transaction Report

Form 4
Period: 2022-04-26
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-04-26+45,00045,000 total
    Exercise: $1.51Exp: 2032-04-25Common Stock (45,000 underlying)
Footnotes (1)
  • [F1]This option vests in substantially equal monthly installments over four years.

Documents

1 file
  • 4
    ownership.xmlPrimary